|
Market Closed -
Other stock markets
|
Pre-market 20:00:00 | |||
| 36.38 USD | -1.89% |
|
32.94 | -9.47% |
| 07-07 | Race to launch weight-loss pills heats up as smaller players advance | RE |
| 07-07 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| Market Cap | 4.22B 3.7B 3.42B 3.15B 5.94B 407B 6.03B 40.92B 16.04B 199B 15.86B 15.51B 687B | P/E 2026 * |
-7.57x | P/E 2027 * | -7.86x |
|---|---|---|---|---|---|
| Enterprise Value | 3.77B 3.31B 3.06B 2.81B 5.31B 364B 5.39B 36.56B 14.33B 178B 14.17B 13.86B 613B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
97.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Viking Therapeutics, Inc.
| 1 day | -1.89% | ||
| 1 week | -4.56% | ||
| Current month | -6.74% | ||
| 1 month | +19.75% | ||
| 3 months | +2.39% | ||
| 6 months | +8.53% | ||
| Current year | +3.41% |
| 1 week | 35.29 |  | 38.37 |
| 1 month | 30.52 | | 42.79 |
| Current year | 25.77 | | 42.79 |
| 1 year | 22.96 | | 43.15 |
| 3 years | 8.28 | | 99.41 |
| 5 years | 2.02 | | 99.41 |
| 10 years | 0.88 | | 99.41 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Lian
CEO | Chief Executive Officer | 60 | 2012-09-23 |
Gregory Zante
DFI | Director of Finance/CFO | 55 | 2021-01-03 |
Hubert Chen
CTO | Chief Tech/Sci/R&D Officer | 57 | 2026-06-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Lawson Macartney
CHM | Chairman | 68 | 2015-04-30 |
Brian Lian
CHM | Chairman | 60 | 2012-09-23 |
Matthew Foehr
BRD | Director/Board Member | 53 | 2014-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/1/26 | Free | Chief Technology Officer | 190,000 | 0.1636% | ||
| 3/10/26 | Buy | Executive/Senior Manager | 4,475 | 0.0039% | ||
| 1/12/26 | Free | Executive/Senior Manager | 180,000 | 0.1592% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.89% | -4.56% | +13.65% | +139.34% | 4.31B | |
| +0.21% | -0.79% | +53.17% | +57.39% | 53.83B | |
| +5.37% | +0.75% | +50.39% | +83.03% | 52.1B | |
| -1.20% | -1.94% | +4.35% | +402.68% | 23.48B | |
| +0.74% | +2.32% | -16.23% | -14.44% | 23.13B | |
| +3.46% | +0.79% | +34.01% | -4.47% | 19.36B | |
| -1.18% | -1.15% | +30.12% | -32.02% | 17.56B | |
| -1.67% | -8.56% | +163.95% | +284.69% | 15.2B | |
| +3.62% | -2.42% | +29.70% | +663.64% | 14.83B | |
| -0.70% | -0.91% | +24.87% | +179.47% | 14.06B | |
| Average | +0.68% | -2.65% | +38.80% | +175.93% | 23.79B | |
| Weighted average by Cap. | +1.42% | -2.39% | +40.96% | +139.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -563M -493M -456M -420M -792M -54.29B -804M -5.45B -2.14B -26.56B -2.11B -2.07B -91.52B | -587M -515M -476M -438M -826M -56.64B -839M -5.69B -2.23B -27.72B -2.21B -2.16B -95.49B |
| Net Debt | -450M -395M -365M -336M -633M -43.43B -643M -4.36B -1.71B -21.25B -1.69B -1.65B -73.21B | -523M -459M -424M -390M -736M -50.48B -748M -5.07B -1.99B -24.7B -1.97B -1.92B -85.09B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | US$36.38 | -1.89% | 1,908,523 |
| 26-07-17 | US$37.08 | +1.95% | 1,922,445 |
| 26-07-16 | US$36.37 | -3.81% | 1,529,156 |
| 26-07-15 | US$37.81 | -0.42% | 1,228,470 |
| 26-07-14 | US$37.97 | -0.39% | 1,341,034 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VKTX Stock
Select your edition
All financial news and data tailored to specific country editions
